Media Availability: Study of Antibody Evolution Charts Course toward HIV Vaccine

Media Availability: Study of Antibody Evolution Charts Course toward HIV Vaccine

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases           Visit us on the Web Study of Antibody Evolution Charts Course toward HIV Vaccine In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2. Many researchers believe that if a vaccine elicited potent antibodies to a specific conserved site in the V1V2 region, one of a handful of sites that remains constant on the fast-mutating virus, then the vaccine could protect people from HIV infection. The new findings point the way toward a vaccine that would generate such antibodies. Learn more about this advance.